Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Physics in Medicine and Biology|July 7, 2017
Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404Abigail E Besemer, Benjamin Titz, Joseph J Grudzinski, et al.
Neuro-Oncology|January 31, 2006
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021H Ian Robins, M Won, Wendy F Seiferheld, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapyJarrod B Adkison, Wolfgang Tomé, Songwon Seo, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
Neuro-Oncology Advances|June 7, 2024
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomasColin M Harari, Adam R Burr, Brett A Morris, et al.
Neurosurgery|October 7, 2020
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive GlioblastomaDavid M Peereboom, Xiaobu Ye, Tom Mikkelsen, et al.
Molecular Imaging and Biology|June 12, 2019
[<sup>124</sup>I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain TumorsLance T Hall, Benjamin Titz, Nishanta Baidya, et al.
Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118)Jonathan P S Knisely, Brian Berkey, Arnab Chakravarti, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
Pageof 11